Triclosan-coated sutures reduce the risk of surgical site infections: A systematic review and meta-analysis

Infection Control and Hospital Epidemiology

Volumn 36, Issue 2, 2015, Pages 169-179

  Apisarnthanarak, Anucha ^a   Singh, Nalini ^b   Bandong, Aila Nica ^c   Madriaga, Gilbert ^c  

^a THAMMASAT UNIVERSITY HOSPITAL   (Thailand)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

POLIGLECAPRONE; POLYGLACTIN; TRICLOSAN; TOPICAL ANTIINFECTIVE AGENT;

ARTICLE; COLORECTAL SURGERY; CONFIDENCE INTERVAL; DEVICE COMPARISON; GENETIC HETEROGENEITY; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; POLYDIOXANONE SUTURE; POLYGLACTIN SUTURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGRESSION ANALYSIS; RISK FACTOR; SENSITIVITY ANALYSIS; SURGICAL INFECTION; SYSTEMATIC REVIEW; ABDOMEN; SURGERY; SURGICAL WOUND INFECTION; SUTURE;

ABDOMEN; ANTI-INFECTIVE AGENTS, LOCAL; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURGICAL WOUND INFECTION; SUTURES; TRICLOSAN;

EID: 84922718227     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1017/ice.2014.22     Document Type: Article

References (43)

1. World Health Organization. Health care-associated infections:fact sheet. http://www.who.int/. Accessed May 19, 2014.
2. Magill S, Edwards J, Bamberg W, et al. Multistate pointprevalence survey of healthcare-associated infections. New Engl J Med 2014;370:1198–1208.
3. Allegranzi B, Nejad SB, Combescure C, et al. Burden of endemic healthcare-associated infection in developing countries: systematic review and meta-analysis. Lancet 2011;377:228–241.
4. Rosenthal VD, Richtmann R, Singh S, et al. Surgical site infections,Inter national Nosocomial Infection Control Consortium (INICC) report, data summary of 30 countries for 2005–2010.Infect Control Hosp Epidemiol 2013;34:597–604.
5. Chang WK, Srinivasa S, Morton R, et al. Triclosan-impregnated sutures to decrease surgical site infections: systematic review and meta-analysis of randomized trials. Ann Surg 2012;255:854–859.
6. Wang ZX, Jiang CP, Cao Y, et al. Systematic review and meta-analysis of triclosan-coated sutures for the prevention of surgical-site infection. Br J Surg 2013;100:465–473.
7. Edmiston CE, Daoud FC, Leaper D. Is there an evidence-based argument for embracing an antimicrobial (triclosan)-coated suture technology to reduce the risk for surgical-site infections? A meta-analysis. Surgery 2013;154:89–100.
8. Daoud FC, Edmiston CE, Leaper D. Meta-analysis of prevention of surgical site infections following incision closure with triclosan-coated sutures: robustness to new evidence. Surg Infect 2014;15:165–181.
9. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. http://www.cochrane-handbook.org. Published 2011. Accessed May 19, 2014.
10. Shrier I, Steele RJ, Platt RW, et al. Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles. Am J Epidemiol 2007;166:1203–1209.
11. Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. http://www.ohri.ca/. Accessed May 19, 2014.
12. Garner JS. CDC guideline for prevention of surgical wound infections, 1985. Supersedes guideline for prevention of surgical wound infections published in 1982. (Originally published in November 1985). Revised Infect Control 1986;7:193–200.
13. Baracs J, Huszar O, Sajjadi SG, et al. Surgical site infections after abdominal closeure in colorectal surgery using triclosan-coated absorbable suture (PDS Plus) vs uncoated sutures (PDS II): a randomized multicenter study. Surg Infect 2011;12:483–489.
14. Chen SY, Chen TM, Dai NT, et al. Do antibacterial-coated sutures reduce wound infection in head and neck cancer reconstruction? Eur J Surg Oncol 2011;37:300–304.
15. DeFazio A, Datta MS, Nezhat C. Does the use of Vicryl Plus antibacterial suture decrease the incidence of umbilical infection when compared to Vicryl suture? [abstract 90]. J Minim Invasive Gynecol 2005;12:5.
16. Deliaert AE, Van den Kerckhove E, Tuinder S, et al. The effect of triclosan-coated sutures in wound healing. A double-blind randomized prospective pilot study. J Plast Reconstr Aesthet Surg 2008;62:771–773.
17. Diener MK, Knebel P, Kieser M, et al. Effectiveness of triclosancoated PDS Plus versus uncoated PDS II sutures for prevention of surgical site infection after abdominal wall closure: the randomized controlled PROUD trial. Lancet 2014;384:142–152.
18. Ford HR, Jones P, Gaines B, et al. Intraoperative handling and wound healing: controlled clinical trial comparing coated VICRYL® Plus antibacterial suture (coated Polyglactin 910 suture with triclosan) with coated VICRYL® suture (coated Polyglactin910 suture). Surg Infect 2005;6:3.
19. Galal I, El-Hindawy K. Impact of using triclosan-antibacterial sutures on incidence of surgical site infection. Am J Surg 2011; 202:133–138.
20. Hoshino S, Yoshida Y, Tanimura S, et al. A study of the efficacy of antibacterial sutures for surgical site infection: a retrospective controlled trial. Int Surg 2013;98:129–132.
21. Huszar O, Baracs J, Toth M, et al. A comparison of wound infection rates after colon and rectal surgeries using triclosancoated suture-a multi-center, randomized clinical study.Magyar Sebészet 2012;65:83–91.
22. Isik I, Selimen D, Senay S, et al. Efficiency of antibacterial suture material in cardiac surgery: a double-blind randomized prospective study. Heart Surg Forum 2012;15:E40–E45.
23. Justinger C, Moussavian MR, Schlueter C, et al. Antibiotic coating of abdominal closure sutures and wound infection. Surgery 2009;145:330–334.
24. Justinger C, Schuld J, Sperling J. Triclosan-coated sutures reduce wound infections after hepatobiliary surgery-a prospective nonrandomized clinical pathway driven study. Langenbecks Arch Surg 2011;396:845–850.
25. Justinger C, Slotta J, Ningel S, et al. Surgical-site infection after abdominal wall closure with triclosan-impregnated polydioxanone sutures: results of a randomized clinical pathway facilitated trial. J Surg 2013;154:589–595.
26. Khachatryan N, Dibirov M, Omelyanovsky V, et al. Prevention of postoperative infections in abdominal surgery using reabsorbable suture with antibacterial activity (Vicryl Plus) versus reabsorbable sutures[abstract28]. In: 24th European Congress on Surgical Infections (Leon, Spain) Surg Infect 2011;12:2.
27. Laas E, Poilroux C, Bézu C, et al. Antibacterial-coated suture in reducing surgical site infection in breast surgery: a prospective study. Int J Breast Cancer 2012 doi: 10.1155/2012/819578.
28. Mattavelli I, Nespoli L, Alfieri S, et al. Triclosan-coated suture to reduce surgical site infection after colorectal surgery [abstract31].Surg Infect 2011;12:A14–A15.
29. Mingmalairak C, Ungbhakorn P, Paocharoen V. Efficacy of antimicrobial coating suture coated Polyglactin 910 with Tricosan (Vicryl Plus) compared with Polyglactin 910 (Vicryl) in reduced surgical site infection of appendicitis, double-blind randomized control trial, preliminary safety report. J Med Assoc Thai 2009;92:6.
30. Nakamura T, Kashimura N, Noji T, et al. Triclosan-coated sutures reduce the incidence of wound infections and the costs after colorectal surgery: a randomized controlled trial. J Surg 2013;53:576–583.
31. Okada N, Nakamura T, Ambo Y, et al. Triclosan-coated abdominal closure sutures reduce the incidence of surgical site infections after pancreaticoduodenectomy. Surg Infect 2014;15:305–309.
32. Rasic Z, Schwarz D, Adam VN, et al. Efficacy of antimicrobial triclosan-coated polyglactin 910 (Vicryl Plus) suture for closure of the abdominal wall after colorectal surgery. Coll Antropol 2011;2:439–443.
33. Rozzelle CJ, Leonardo J, Li AV. Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: a prospective, double-blinded, randomized controlled trial. J Neurosurg Pediatr 2008;2:111–117.
34. Seim B, Tønnessena T, Woldbaeka P. Triclosan-coated sutures do not reduce leg wound infections after coronary artery bypass grafting. Interact Cardiovasc Thorac Surg 2012;15:411–415.
35. Singh H, Emmert MY, Sakaguchi H, et al. Antibacterial suture reduces surgical site infections in coronary artery bypass grafting [abstract PP16]. In: 5th International Meeting of The Onassis Cardiac Surgery Center. Heart Surgery Forum (Athens). 2010;13:S85.
36. Thimour-Bergström L, Roman-Emanue C, Scherstén H, et al. Triclosan-coated sutures reduce surgical site infection after open vein harvesting in coronary artery bypass grafting patients: arandomized controlled trial. Eur J Cardiothorac Surg 2013;44:931–938.
37. Turtiainen J, Saimanen ET, Makinen K, et al. Effect of triclosancoated sutures on the incidence of surgical wound infection after lower limb revascularization surgery: a randomized controlled trial. World J Surg 2012;36:2528–2534.
38. Ueno M, Saito W, Yamagata M, et al. Triclosan-coated sutures reduce wound infections after spinal surgery: a retrospective, nonrandomized, clinical study. Spine [in press].
39. Williams N, Sweetland H, Goyal S, et al. Randomized trial of antimicrobial-coated sutures to prevent surgical site infection after breast cancer surgery. Surg Infect 2011;12:469–474.
40. Zhang Z, Zhang H, Fang X, et al. Cosmetic outcome and surgical site infection rates of antibacterial absorbable (Polyglactin 910) suture compared to Chinese silk suture in breast cancer surgery: arandomized pilot research. Chin Med J 2011;124:719–724.
41. Zhuang C, Cai G, Wang Y. Comparison of two absorbable sutures in abdominal wall incision. J Clin Rehab Tissue Eng Res 2009; 13:4045–4048.
42. Yokoe DS, Anderson DJ, Berenholtz SM, et al. Introduction to“A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates.” Infect Control Hosp Epidemiol 2014;35:455–459.
43. Anderson DJ, Podgorny KP, Berríos-Torres SI. Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014;35:605–627.